If wish to subscribe please visit the following link – http://eepurl.com/cvmBlv
Mitochondrial pathway
Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activation – Corey Rogers, Dan A. Erkes, Alexandria Nardone, Andrew E. Aplin, Teresa Fernandes-Alnemri and Emad S. Alnemri. https://www.nature.com/articles/s41467-019-09397-2
Intrinsic apoptosis shapes the tumor spectrum linked to inactivation of the deubiquitinase BAP1 – Meng He, Mira S. Chaurushiya, Joshua D. Webster, Sarah Kummerfeld, Rohit Reja, Subhra Chaudhuri, Ying-Jiun Chen, Zora Modrusan, Benjamin Haley, Debra L. Dugger, Jeffrey Eastham-Anderson, Shari Lau, Anwesha Dey, Roger Caothien, Merone Roose-Girma, Kim Newton, Vishva M. Dixit. https://science.sciencemag.org/content/364/6437/283.abstract
Cytochrome c Deficiency Confers Apoptosome and Mitochondrial Dysfunction in African-American Men with Prostate Cancer – Rahul Kumar, Tariq A. Bhat, Elise M. Walsh, Ajay K. Chaudhary, Jordan O’Malley, Johng S. Rhim, Jianmin Wang, Carl D. Morrison, Kristopher Attwood, Wiam Bshara, James L. Mohler, Neelu Yadav and Dhyan Chandra. http://cancerres.aacrjournals.org/content/79/7/1353
Ceramides bind VDAC2 to trigger mitochondrial apoptosis – Shashank Dadsena, Svenja Bockelmann, John G. M. Mina, Dina G. Hassan, Sergei Korneev, Guilherme Razzera, Helene Jahn, Patrick Niekamp, Dagmar Müller, Markus Schneider, Fikadu G. Tafesse, Siewert J. Marrink, Manuel N. Melo and Joost C. M. Holthuis. https://www.nature.com/articles/s41467-019-09654-4
Mitochondrial pathway – Bcl-2 family proteins
BAX Activation: Mutations Near Its Proposed Non-canonical BH3 Binding Site Reveal Allosteric Changes Controlling Mitochondrial Association – Michael A. Dengler, Adeline Y. Robin, Leonie Gibson, Mark X. Li, Jarrod J. Sandow, Sweta Iyer, Andrew I. Webb, Dana Westphal, Grant Dewson, Jerry M. Adams. https://www.cell.com/cell-reports/fulltext/S2211-1247(19)30356-0
Bcl-2 and IP3 compete for the ligand-binding domain of IP3Rs modulating Ca2+ signaling output – Hristina Ivanova, Larry E. WagnerII, Akihiko Tanimura, Elien Vandermarliere, Tomas Luyten, Kirsten Welkenhuyzen, Kamil J. Alzayady, Liwei Wang, Kozo Hamada, Katsuhiko Mikoshiba, Humbert De Smedt, Lennart Martens, David I. Yule, Jan B. Parys, Geert Bultynck. https://link.springer.com/article/10.1007/s00018-019-03091-8
Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors that Demonstrate in vivo Activity in Mouse Xenograft Models of Human Cancer – Lee T, Christov PP, Shaw S, Tarr JC, Zhao B, Veerasamy N, Jeon KO, Mills JJ, Bian Z, Sensintaffar JL, Arnold AL, Fogarty SA, Perry E, Ramsey HE, Cook R, Hollingshead M, Davis Millin M, Lee KM, Koss B, Budhraja A, Opferman JT, Kim K, Arteaga CL, Moore WJ, Olejniczak ET, Savona MR, Fesik SW. https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01991
Structural insights into BCL2 pro-survival protein interactions with the key autophagy regulator BECN1 following phosphorylation by STK4/MST1 – Erinna F. Lee, Nicholas A. Smith, Tatiana P. Soares da Costa, Nastaran Meftahi, Shenggen Yao, Tiffany J. Harris, Sharon Tran, Anne Pettikiriarachchi, Matthew A. Perugini, David W. Keizer, Marco Evangelista, Brian J. Smith and W. Douglas Fairlie. https://www.tandfonline.com/doi/full/10.1080/15548627.2018.1564557
Avoiding adsorption of Bcl-2 proteins to plasticware is important for accurate quantitation – Colin Hockings, Sweta Iyer, Rachel T. Uren and Ruth M. Kluck. https://www.nature.com/articles/s41418-019-0284-y
Interactions between cancer-associated fibroblasts and tumor cells promote MCL-1 dependency in estrogen receptor-positive breast cancers – Louault, T. L Bonneaud, C. Séveno, P. Gomez-Bougie, F. Nguyen, F. Gautier, N. Bourgeois, D. Loussouarn, O. Kerdraon, S. Barillé-Nion, P. Jézéquel, M. Campone, M. Amiot, P. P. Juin and F. Souazé. https://www.nature.com/articles/s41388-018-0635-z
Death receptors
T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy – Tori N. Yamamoto, Ping-Hsien Lee, Suman K. Vodnala, Devikala Gurusamy, Rigel J. Kishton, Zhiya Yu, Arash Eidizadeh, Robert Eil, Jessica Fioravanti, Luca Gattinoni, James N. Kochenderfer, Terry J. Fry, Bulent Arman Aksoy, Jeffrey E. Hammerbacher, Anthony C. Cruz, Richard M. Siegel, Nicholas P. Restifo and Christopher A. Klebanoff. https://www.jci.org/articles/view/121491
Impact of p53 status on TRAIL-mediated apoptotic and non-apoptotic signaling in cancer cells – Anna Willms, Hella Schittek, Sascha Rahn, Justyna Sosna, Ufuk Mert, Dieter Adam, Anna Trauzold. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0214847
Necroptosis, RIPK1
Direct Activation of Human MLKL by a Select Repertoire of Inositol Phosphate Metabolites – Dan E. McNamara, Cole M. Dovey, Andrew T. Hale, Giovanni Quarato, Christy R. Grace, Cristina D. Guibao, Jonathan Diep, Amanda Nourse, Casey R. Cai, Hong Wu, Ravi C. Kalathur, Douglas R. Green, John D. York, Jan E. Carette, Tudor Moldoveanu. https://www.cell.com/cell-chemical-biology/fulltext/S2451-9456(19)30106-0
Serine 25 phosphorylation inhibits RIPK1 kinase-dependent cell death in models of infection and inflammation – Yves Dondelinger, Tom Delanghe, Dario Priem, Meghan A. Wynosky-Dolfi, Daniel Sorobetea, Diego Rojas-Rivera, Piero Giansanti, Ria Roelandt, Julia Gropengiesser, Klaus Ruckdeschel, Savvas N. Savvides, Albert J. R. Heck, Peter Vandenabeele, Igor E. Brodsky and Mathieu J. M. Bertrand. https://www.nature.com/articles/s41467-019-09690-0
RIPK1 prevents TRADD-driven, but TNFR1 independent, apoptosis during development – Holly Anderton, Esther Bandala-Sanchez, Daniel S Simpson, James A Rickard, Ashley P Ng, Ladina Di Rago, Cathrine Hall, James E Vince, John Silke, Gianmaria Liccardi and Rebecca Feltham. https://www.nature.com/articles/s41418-018-0166-8
Ferroptosis
A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis – Yilong Zou, Michael J. Palte, Amy A. Deik, Haoxin Li, John K. Eaton, Wenyu Wang, Yuen-Yi Tseng, Rebecca Deasy, Maria Kost-Alimova, Vlado Dančík, Elizaveta S. Leshchiner, Vasanthi S. Viswanathan, Sabina Signoretti, Toni K. Choueiri, Jesse S. Boehm, Bridget K. Wagner, John G. Doench, Clary B. Clish, Paul A. Clemons and Stuart L. Schreiber. https://www.nature.com/articles/s41467-019-09277-9
The Deubiquitylase OTUB1 Mediates Ferroptosis via Stabilization of SLC7A11 – Tong Liu, Le Jiang, Omid Tavana and Wei Gu. http://cancerres.aacrjournals.org/content/79/8/1913
Mechanistic basis for impaired ferroptosis in cells expressing the African-centric S47 variant of p53 – Julia I-Ju Leu, Maureen E. Murphy and Donna L. George. https://www.pnas.org/content/116/17/8390.abstract?etoc
Miscellanous
Lysosomal Machinery Drives Extracellular Acidification to Direct Non-apoptotic Cell Death [of the nurse cell] – Albert A. Mondragon, Alla Yalonetskaya, Anthony J. Ortega, Yuanhang Zhang, Oandy Naranjo, Johnny Elguero, Won-Suk Chung, Kimberly McCall. https://www.cell.com/cell-reports/fulltext/S2211-1247(19)30350-X?
Comments
Methods for monitoring the progression of cell death, cell disassembly and cell clearance – Lanzhou Jiang and Ivan K. H. Poon. https://link.springer.com/article/10.1007/s10495-018-01511-x
Navigating the Fas lane to improved cellular therapy for cancer – Madhav V. Dhodapkar. https://www.jci.org/articles/view/127581
MAVS‐induced mitochondrial membrane remodeling – Hector Flores‐Romero, Ana J. García‐Sáez. https://febs.onlinelibrary.wiley.com/doi/10.1111/febs.14822
DUBbing Ferroptosis in Cancer Cells – Boyi Gan. http://cancerres.aacrjournals.org/content/79/8/1749
Conference: NON-APOPTOTIC ROLES OF APOPTOTIC PROTEINS
September 22-25, 2019, Weizmann Institute of Science